Cite

HARVARD Citation

    He, J. et al. (n.d.). AB0525 Safety and Efficiency of Low-Dose Interleukin-2 Treatment in Systemic Lupus Erythematosus. Annals of the rheumatic diseases. pp. 1075-1076. [Online]. 
  
Back to record